Post Tue Jul 09, 2024 7:47 pm

2024-Mo et al-Nat Med

"Metronomic chemotherapy plus anti-PD-1 in metastatic breast cancer: a Bayesian adaptive randomized phase 2 trial"
Hongnan Mo, Yongpei Yu, Xiaoying Sun, Hewei Ge, Lanlan Yu, Xiuwen Guan, Jingtong Zhai, Aihua Zhu, Yuhan Wei, Jinjing Wang, Xiaoyan Yan, Haili Qian, Binghe Xu, Fei Ma
Nat Med. 2024
https://doi.org/10.1038/s41591-024-03088-2

- no CyTOF dataset accession given